
Currently out of the existing stock ratings of Jessica Tassan, 40 are a HOLD (20.51%), 2 are a SELL (1.03%), 153 are a BUY (78.46%).
Analyst Jessica Tassan, currently employed at PIPER SANDLER, has had 53.5% of price targets met with an average potential upside of 21.07%, reached in 125 days on average.
Jessica Tassan has documented 384 price targets and ratings displayed on 28 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on CI, Cigna Corp at 11-Nov-2026.
Analyst best performing recommendations are on NXGN.
The best stock recommendation documented was for HCAT (HEALTH CATALYST) on 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%), with a performance score of 26.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
3 years 3 days ago
(17-Nov-2023)
0/1 (0%)
$4.37 (57.27%)
Hold
$0.5
$2.5
3 years 3 months 6 days ago
(14-Aug-2023)
0/5 (0%)
$3.12 (70.54%)
Buy
$0.8
$12
3 years 3 months 9 days ago
(11-Aug-2023)
0/3 (0%)
$3.48 (64.74%)
Buy
$17
3 years 3 months 9 days ago
(11-Aug-2023)
0/1 (0%)
$4.88 (40.26%)
Buy
3 years 7 months 17 days ago
(03-Apr-2023)
4/4 (100%)
$2.26 (47.68%)
338
Which stock is Jessica Tassan most bullish on?
Which stock is Jessica Tassan most reserved on?
What Year was the first public recommendation made by Jessica Tassan?